Assessment of risk factors and human papillomavirus (HPV) related pathogenetic mechanisms of CIN in HIV-positive and HIV-negative women. Study design and baseline data of the HPV-PathogenISS study

European Journal of Gynaecological Oncology

Volumn 25, Issue 6, 2004, Pages 689-698

  Branca, M ^a   Costa, S ^b   Mariani, L ^c   Sesti, F ^d   Agarossi, A ^e   Di Carlo, A ^f   Galati, M ^c,f   Benedetto, A ^g   Ciotti, M ^g   Giorgi, C ^a   Criscuolo, A ^d   Valieri, M ^e   Favalli, C ^g   Paba, P ^g   Santini, D ^b   Piccione, E ^d   Alderisio, M ^a   De Nuzzo, M ^b   Di Bonito, L ^h   Syrjanen K ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^g TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^h MAGGIORE HOSPITAL   (Italy)

Author keywords

CIN; Colposcopy; HIV; HPV; Interaction; Intermediate endpoint markers; Pap smear; Pathogenesis; Risk factors

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CARCINOMA IN SITU; COLPOSCOPY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTOR; SEROLOGY; SEXUALITY; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; DNA PRIMERS; DNA, VIRAL; FEMALE; HIV INFECTIONS; HUMANS; ITALY; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 4644284350     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. IARC Monographs on the evaluation of carcinogenic risks to humans. Vol. 64. Papillomavirusus. IARC, Lyon 1995, 1.
2. Syrjänen K.J., Syrjänen S.M.: "Papillomavirus Infections in Human Pathology". New York, London, Wiley, 2000, 1.
3. Franco E., Monsonego J. (eds.). New Developments in Cervical Cancer Screening and Prevention. Oxford, Blackwell Science, 1997, 1.
4. Burd E.M.: "Human papillomavirus and cervical cancer". Clin. Microbiol. Rev., 2003, 16, 1.
5. Franceschi S., Rajkumar T., Vaccarella S., Gajalakshmi V., Sharmila A., Snijders PJ. et al.: "Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study". Int. J. Cancer, 2003, 107, 127.
6. Goncalves M.A., Burattini M.N., Donadi E.A., Massad E.: "Anogenital warts contributing to the risk of squamous intraepithelial lesions among HIV-positive women of Sao Paulo, Brazil". Int. J. Std. AIDS, 2003, 14, 309.
7. Wright T., Tedd V., Ellerbrock M.D., Chiasson M.A., Van Devanter N., Xiao-Wei S.: "Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears". Obstet. Gynecol., 1994, 84, 591.
8. Branca M., Migliore G., Giuliani M. et al.: "Squamous Intraepithelial Lesions (SILs) and HPV associated changes in HIV infected women or at risk of HIV". Eur. J. Gynecol. Oncol., 2000, 21, 155.
9. Cappiello G., Garbuglia A.R., Salvi R., Rezza G., Branca M. and the DIANAIDS Collaborative Study Group: "HIV infection increases the risk of squamous intraepithelial lesion in women with HPV infection: an analysis of HPV genotypes". Int. J. Cancer, 1997, 72, 982.
10. Rezza G., Giuliani M., Branca M. et. al: "Determinants of squamous intraepithelial lesions (SIL) in women with, or at risk for, HIV-I infection". Eur. J. Epidemiol., 1997, 13, 937.
11. Branca M., Garbuglia A.R., Benedetto A., Cappiello T., Leoncini L., Migliore G. et al.: "Factors predicting the persistence of genital human papillomavirus infections and Pap smear abnormality in HIV-positive and HIV-negative women during prospective follow-up". Int. J. Std. AIDS, 2003, 14, 417.
12. Carreras R., Fuste P., Castellanos M.E.: "Cervical intra-epithelial neoplasia in HIV-positive women and women with AIDS". Int. J. Gynecol. Obstet., 1997, 58, 325.
13. Rezza G., Giuliani M., Serraino D., Branca M., Benedetto A., Garbuglia A. et al.: "Risk factors for cervical presence of human papillomavirus DNA among women at risk for HIV infection. DIANAIDS Collaborative Study Group". Epidemiol. Infect., 1998, 121, 173.
14. Amit A., Edwards C.L., Athey P., Kaplan A.L.: "Extensive subcutaneous metastases from squamous cell carcinoma of the cervix in patient with HIV". Int. J. Gynecol. Cancer, 2001, 11, 78.
15. Calore E.E., Pereira S.M., Cavaliere M.J.: "Progression of cervical lesions in HIV-seropositive women: a cytological study". Diagn. Cytopathol., 2001, 24, 117.
16. Moodley M., Moodley J., Kleinschmidt I.: "Invasive cervical cancer and human immunodeficiency virus (HIV) infection: a South African perspective". Int. J. Gynecol. Cancer, 2001, 11, 194.
17. Delmas M.C., Larsen C., van Benthem B., Hamers F.F., Bergeron C., Poveda J.D. et al.: "Cervical squamous intraepithelial lesions in HIV-infected women: prevalence, incidence and regression. European Study Group on Natural History of HIV Infection in Women". AIDS, 2000, 14, 1775.
18. Hawes S.E., Critchlow C.W., Faye Niang M.A., Diouf M.B., Diop A., Toure P. et al.: "Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections". J. Infect. Dis., 2003, 188, 555.
19. Dorrucci M., Suligoi B., Serraino D., Tirelli U., Rezza G.: "Incidence of invasive cervical cancer in a cohort of HIV-seropositive women before and after the introduction of highly active anti-retroviral therapy". J. Acquir. Immune Defic. Syndr., 2001, 26, 377.
20. Grulich A.E.: "Update: cancer risk in persons with HIV/AIDS in the era of combination antiretroviral therapy". AIDS Read., 2000, 10, 341.
21. Clarke B., Chetty R.: "Postmodern cancer: the role of human immunodeficiency virus in uterine cervical cancer". Mol. Pathol., 2002, 55, 19.
22. Stein M.D., Cunningham W.E., Nakazono T., Turner B.J., Andersen R.M., Bozzette S.A. et al.: "Screening for cervical cancer in HIV-infected women receiving care in the United States". J. Acquir. Immune Defic. Syndr., 2001, 27, 463.
23. Holmes K.K.: "Preventing genital infections with human papillomavirus: lessons learned from the HIV epidemic". J. Clin. Virol., 2000, 19, 91.
24. Williams A.B.: "Gynecologic care for women with HIV infection". J. Obstet. Gynecol. Neonatal. Nurs., 2003, 32, 87.
25. Branca M., Rossi E., Alderisio M., Migliore G., Morosini P.L., Vecchione A. et al: "Performance of cytology and colposcopy in diagnosis of cervical intraepithelial neoplasia (CIN) in HIV-positive and HIV-negative women". Cytopathol., 2001, 12, 84.
26. Branca M., Migliore G., Giuliani M., Morosini PL., Mudu P, Cappiello G. et al.: "Using the number of koilocytes to predict HIV serostatus in women with HPV-associated SIL". Acta Cytol., 2000, 44, 1000.
27. Del Mistro A., Chieco B.L.: "HPV-related neoplasias in HIV-infected individuals". Eur. J. Cancer, 2001, 37, 1227.
28. Faro S.: "Human papillomavirus typing in HIV-positive women". Infect. Dis. Obstet. Gynecol., 2001, 9, 123.
29. Hameed M., Fernandes H., Skurnick J., Moore D., Kloser P., Heller D.: "Human papillomavirus typing in HIV-positive women". Infect. Dis. Obstet. Gynecol., 2001, 9, 89.
30. Goldie S.J., Freedberg K.A., Weinstein M.C., Wright T.C., Kuntz K.M.: "Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus". Am. J. Med., 2001, 111, 140.
31. Stein M.D., Cunningham W.E., Nakazono T., Turner B.J., Andersen R.M., Bozzette S.A. et al.: "Screening for cervical cancer in HIV-infected women receiving care in the United States". J. Acquir. Immune Defic. Syndr., 2001, 27, 463.
32. Torrisi A., Del Mistro A., Onnis G.L., Merlin F., Bertorelle R., Minucci D.: "Colposcopy, cytology and HPV-DNA testing in HIV-positive and HIV-negative women". Eur. J. Gynaecol. Oncol., 2000, 21, 168.
33. Womack S.D., Chirenje Z.M., Gaffikin L., Blumenthal P.D., McGrath J.A., Chipato T. et al.: "HPV-based cervical cancer screening in a population at high risk for HIV infection". Int. J. Cancer, 2000, 85, 206.
34. Buonaguro P.M., Tornesello M.L., Buonaguro L., Del Gaudio E., Beth-Giraldo E., Giraldo G.: "Role of HIV as cofactor in HPV oncogenesis: in vitro evidences of virus interactions". Antibiot. Chemother., 1994, 46, 102.
35. Arany I., Tyring S.K.: "Systemic immunosuppression by HIV infection influences HPV transcription and thus local immune responses in condyloma acuminatum". Int. J. Std. AIDS, 1998, 9, 268.
36. Arany I., Evans T., Tyring S.K.: "Tissue specific HPV expression and downregulation of local immune responses in condylomas from HIV seropositive individuals". Sex Transm. Infect., 1998, 74, 349.
37. Smith M.K., Goral M.A., Wright J.H., Matrisian L.M., Morris R.J., Kleinszanto A.J.P., Gilmour S.K.: "Ornithine decarboxylase overexpression leads to increased epithelial tumor invasiveness". Cancer Res., 1997, 57, 2104.
38. Lee D., Hwang S.O., Kim J., Choe J.: "Functional interaction between p/CAF and human papillomavirus E2 protein". J. Biol. Chem., 2001, 275, 7045.
39. th International Multidisciplinary Congress EUROGIN 2003. Paris, April 13-16, 2003.
40. Smith J.H.: "Bethesda 2001". Cytopathology, 2002, 13, 4.
41. Stafl A., Wilbanks G.D.: "An international terminology of colposcopy: report of the Nomenclature Committee of the International Federation of Cervical Pathology and Colposcopy". Obstet. Gynecol., 1991, 77, 313.
42. Costa S., De Nuzzo M., Bonavita B., Infante F.E., Marinelli M., Rambelli V., Rubino A.: "Cervical Loop Excision: Colposcopy limits in pre-surgical assessment of CIN Lesions". Tumori, 2001, 87, 13.
43. Bauer H.M., Greer C.E., Manos M.: "Determination of genital human Papillomavirus infection using consensus PCR". In: C.S. Herrington and J.O.D. McGee (eds.), Diagnostic Molecular Pathology: A Practical Approach. Oxford, Oxford University Press, 1992, 132.
44. Fujinaga Y., Shimada M., Okazawa K., Fukushima M., Kato I., Fujinaga K.: "Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction". J. Gen. Virol., 1991, 72, 1039.
45. Kurvinen K., Syrjänen K., Syrjänen S.: "p53 and bcl-2 proteins as prognostic markers in Human papillomavirus-associated cervical lesions". J. Clin. Oncol., 1996, 14, 2120.
46. Palefsky J.M.: "Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy". Curr. Opin. Oncol., 2003, 15, 382.